Delivery Order SPE2DB24D1006-SPE2DB25FCEQV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 27 mg tablets (100-count units) with a ceiling value of $6,100.05. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is set to be completed by May 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.76 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on June 27, 2025, with completion expected by June 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $9,672.59. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Concerta ER 27 mg tablets (100-count units) with a ceiling value of $53,606.40. This firm fixed-price delivery order, with an ultimate completion date of May 5, 2025, was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER 54 mg tablets (100-count packaging) with a ceiling value of $6,373.92. This firm fixed-price delivery order, which is not associated with any set-aside program, represents a competitively awarded transaction under the company's broader pharmaceutical supply agreement with DLA. The product will be delivered to the place of performance in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $29,314.76 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count units) under a firm fixed-price contract. The award was made on April 23, 2025, with an ultimate completion date of April 24, 2025. This non-set-aside delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's critical role in supporting...
- The Defense Logistics Agency awarded a $2,826.19 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on May 2, 2025, with a completion date of May 5, 2025. This contract is a firm fixed price delivery order with no set-aside designation, competitively awarded to fulfill pharmaceutical supply needs for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Concerta ER 18 mg tablets (100 count) with a contract value of $3,513.92. This is a firm fixed-price delivery order with an ultimate completion date of June 4, 2025. The award was made through open competition with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,519.76 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 27 mg tablets (100-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, represents a continuation of services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEQVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Concerta ER 27 mg tablets in a quantity of 100 units, with a ceiling value of $1,801.16. This competitive, non-set-aside award utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of May 13, 2025. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for the Defense Logistics Agency's Medical Supply Chain, regularly fulfilling orders across multiple therapeutic domains including neurological treatments, pain management medications, and other specialized pharmaceuticals. The competitively awarded IDC vehicle under which this order was issued demonstrates the company's established capability to meet federal procurement requirements and supply pharmaceutical commodities to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/12/25 |